124 A platform to identify tumor-specific neoantigens and corresponding T cell receptors
Karla Soria Zavala, Spencer E Mirabile-Brightman, Leslie Montero, Angela Frentzen et autres
0 citationsRegular and Young Investigator Award Abstracts
Karla Soria Zavala
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
7Publications signalées
180Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches
Publications récentes
The spontaneous neoantigen-specific CD4 + T-cell response to a growing tumor is functionally and phenotypically diverse
Ryan Q. Griswold, Spencer E. Brightman, Karla Soria Zavala, Manuel Azaid Ordaz-Arias et autres
2 citationsJournal for ImmunoTherapy of Cancer
The spontaneous neoantigen-specific CD4 + T cell response to a growing tumor is functionally and phenotypically diverse
Ryan Q. Griswold, Spencer E. Brightman, Karla Soria Zavala, Manuel Azaid Ordaz-Arias et autres
1 citationbioRxiv (Cold Spring Harbor Laboratory)
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M. Miller, Zeynep Koşaloğlu, Luise Westernberg, Leslie Montero et autres
22 citationsScience Translational Medicine
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
Joseph S. Dolina, Joey Lee, Spencer E. Brightman, Sara McArdle et autres
72 citationsJournal of Clinical Investigation
Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors
Spencer E. Brightman, Angelica Becker, Rukman R. Thota, Martin S. Naradikian et autres
0 citationsNature Immunology
Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors
Spencer E. Brightman, Angelica Becker, Rukman R. Thota, Martin S. Naradikian et autres
83 citationsNature Immunology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.